The rare association of dermatomyositis secondary to Chikungunya in chronic phase
DOI:
https://doi.org/10.33448/rsd-v10i5.14865Keywords:
Chikingunya Fever; Arthralgia; Autoimmune Diseases; Muscle weakness.Abstract
Chikungunya is an infectious tropical disease caused by Chikungunya virus (CHIKV), an RNA virus that belongs to the alphavirus genus of the family Togaviridae. It is a mosquito-borne viral disease transmitted by bites of Aedes aegypti and Aedes albopictus, most commonly. The disease evolves in three stages: acute, subacute and chronic. The chronic phase begins after 3 months of initial symptoms. Myalgia is one of the most prevalent symptoms in the disease and may be intense. In the literature, some Myopathy cases secondary to Chikungunya in acute phase were described, but few have been reported in the chronic disease. We present a case of a female patient, who developed progressive muscular weakness due to dermatomyositis in 2016 after 2 years of infection with CHIKV.
References
Agarwal, A., Vibha, D., Srivastava, A. K., Shukla, G., & Prasad, K. (2017). Guillain-Barre syndrome complicating chikungunya virus infection. Journal of neurovirology, 23(3), 504–507. https://doi.org/10.1007/s13365-017-0516-1
Alouani, I., Fihmi, N., Zizi, N., & Dikhaye, S. (2017). Dermatomyositis revealing both a metastatic linitis plastica and hepatitis C virus infection. Indian journal of dermatology, venereology and leprology, 83(5), 606–609. https://doi.org/10.4103/ijdvl.IJDVL_697_16
Bandyopadhyay, D., & Ghosh, S. K. (2008). Mucocutaneous features of Chikungunya fever: a study from an outbreak in West Bengal, India. International journal of dermatology, 47(11), 1148–1152. https://doi.org/10.1111/j.1365-4632.2008.03817.x
Blijham, P. J., Hengstman, G. J., Hama-Amin, A. D., van Engelen, B. G., & Zwarts, M. J. (2006). Needle electromyographic findings in 98 patients with myositis. European neurology, 55(4), 183–188. https://doi.org/10.1159/000093866
Brasil. (2015). Monitoramento dos casos de dengue e febre de chikungunya até a Semana Epidemiológica 15. Ministério da Saúde. http://portalsaude.saude.gov.br/images/pdf/2015/maio/04/2015-016---Boletim-Dengue-SE15-2015.pdf.
Callen JP, Wortmann RL. Dermatomyositis. Clin Dermatol. 2006 Sep-Oct;24(5):363-73. doi: 10.1016/j.clindermatol.2006.07.001. PMID: 16966018.
Cardona-Ospina, J. A., Rodriguez-Morales, A. J., & Villamil-Gómez, W. E. (2015). The burden of Chikungunya in one coastal department of Colombia (Sucre): Estimates of the disability adjusted life years (DALY) lost in the 2014 epidemic. Journal of infection and public health, 8(6), 644–646. https://doi.org/10.1016/j.jiph.2015.06.001
Cardona-Ospina, J. A., Villamil-Gómez, W. E., Jimenez-Canizales, C. E., Castañeda-Hernández, D. M., & Rodríguez-Morales, A. J. (2015). Estimating the burden of disease and the economic cost attributable to chikungunya, Colombia, 2014. Transactions of the Royal Society of Tropical Medicine and Hygiene, 109(12), 793–802. https://doi.org/10.1093/trstmh/trv094
Cunha, Rivaldo V da, & Trinta, Karen S. (2017). Chikungunya virus: clinical aspects and treatment - A Review. Memórias do Instituto Oswaldo Cruz, 112(8), 523-531. https://doi.org/10.1590/0074-02760170044
DeWane, M. E., Waldman, R., & Lu, J. (2020). Dermatomyositis: Clinical features and pathogenesis. Journal of the American Academy of Dermatology, 82(2), 267–281. https://doi.org/10.1016/j.jaad.2019.06.1309
Gan, L., & Miller, F. W. (2011). State of the art: what we know about infectious agents and myositis. Current opinion in rheumatology, 23(6), 585–594. https://doi.org/10.1097/BOR.0b013e32834b5457
Guilherme, L., Dulphy, N., Douay, C., Coelho, V., Cunha-Neto, E., Oshiro, S. E., Assis, R. V., Tanaka, A. C., Pomerantzeff, P. M., Charron, D., Toubert, A., & Kalil, J. (2000). Molecular evidence for antigen-driven immune responses in cardiac lesions of rheumatic heart disease patients. International immunology, 12(7), 1063–1074. https://doi.org/10.1093/intimm/12.7.1063
Madan, V., Chinoy, H., Griffiths, C. E., & Cooper, R. G. (2009). Defining cancer risk in dermatomyositis. Part I. Clinical and experimental dermatology, 34(4), 451–455. https://doi.org/10.1111/j.1365-2230.2009.03216.x
Marc Hochberg , M.R. (2018). Rheumatology. (7 ed.). Elsevier.
Mathew, A. J., Goyal, V., George, E., Thekkemuriyil, D. V., Jayakumar, B., Chopra, A., & Trivandrum COPCORD Study Group (2011). Rheumatic-musculoskeletal pain and disorders in a naïve group of individuals 15 months following a Chikungunya viral epidemic in south India: a population based observational study. International journal of clinical practice, 65(12), 1306–1312. https://doi.org/10.1111/j.1742-1241.2011.02792.x
Miller, F. W., Pollard, K. M., Parks, C. G., Germolec, D. R., Leung, P. S., Selmi, C., Humble, M. C., & Rose, N. R. (2012). Criteria for environmentally associated autoimmune diseases. Journal of autoimmunity, 39(4), 253–258. https://doi.org/10.1016/j.jaut.2012.05.001
Morrison, T. E., Oko, L., Montgomery, S. A., Whitmore, A. C., Lotstein, A. R., Gunn, B. M., Elmore, S. A., & Heise, M. T. (2011). A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence. The American journal of pathology, 178(1), 32–40. https://doi.org/10.1016/j.ajpath.2010.11.018
Rahim, A. A., Thekkekara, R. J., Bina, T., & Paul, B. J. (2016). Disability with Persistent Pain Following an Epidemic of Chikungunya in Rural South India. The Journal of rheumatology, 43(2), 440–444. https://doi.org/10.3899/jrheum.141609
Ren, Z., Laumann, A. E., & Silverberg, J. I. (2019). Association of dermatomyositis with systemic and opportunistic infections in the United States. Archives of dermatological research, 311(5), 377–387. https://doi.org/10.1007/s00403-019-01913-0
Rodríguez-Morales, A. J., Cardona-Ospina, J. A., Fernanda Urbano-Garzón, S., & Sebastian Hurtado-Zapata, J. (2016). Prevalence of Post-Chikungunya Infection Chronic Inflammatory Arthritis: A Systematic Review and Meta-Analysis. Arthritis care & research, 68(12), 1849–1858. https://doi.org/10.1002/acr.22900
Seidler, A. M., & Gottlieb, A. B. (2008). Dermatomyositis induced by drug therapy: a review of case reports. Journal of the American Academy of Dermatology, 59(5), 872–880. https://doi.org/10.1016/j.jaad.2008.05.034
YIN, R. K. (2015). Estudo de caso: planejamento e métodos (5a ed.). (C. M. Herrera, Trad.). Porto Alegre: Bookman. (Obra original publicada em 1984).
Zandman-Goddard, G., & Shoenfeld, Y. (2005). Infections and SLE. Autoimmunity, 38(7), 473–485. https://doi.org/10.1080/08916930500285352
Zheng, Q., Zhu, K., Gao, C. N., Xu, Y. P., & Lu, M. P. (2019). Prevalence of Epstein-Barr virus infection and characteristics of lymphocyte subsets in newly onset juvenile dermatomyositis. World journal of pediatrics: WJP, 10.1007/s12519-019-00314-7. Advance online publication. https://doi.org/10.1007/s12519-019-00314-7
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Natacha Campos Arriaga; Louise Cavalcanti Salles; Francisco Theogenes Macedo Silva; Fabrício André Martins da Costa; Cleonisio Leite Rodrigues; Kristopherson Lustosa Augusto
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
